Company Information
USD
7.96
- (2.2%)
NASDAQ:TVTX, TRAVERE THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 25 June 2024 GMT-4
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
Address
3611 Valley Centre Drive
Suite 300
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Ms. Elizabeth E. Reed
General Counsel/Secretary/Senior VP
Mr. Gary A. Lyons
Director/Chairman of the Board
Mr. Ron Squarer
Director
Mr. Timothy P. Coughlin
Director
Mr. John A. Orwin
Director
Dr. Suzanne L. Bruhn, PhD
Director
Mr. Jeffrey A. Meckler
Director
Ms. Sandra E. Poole
Director
Dr. Roy D. Baynes, M.D.,PhD
Director
Mr. William E. Rote
Senior VP, Divisional
Dr. Eric M. Dube, PhD
CEO/Director/President
Mr. Peter Heerma
Other Executive Officer
Ms. Ruth Williams-Brinkley
Director
Ms. Sandra Calvin
Chief Accounting Officer/Senior VP
Dr. Jula Inrig
Chief Medical Officer
Mr. Christopher Cline
CFO
Ownership
Institution Holdings
BlackRock Inc
7,917,860 (10.405%)
Armistice Capital, LLC
7,384,000 (9.703%)
Deep Track Capital, LP
7,370,000 (9.685%)
Vanguard Group Inc
5,515,143 (7.247%)
State Street Corporation
5,352,345 (7.033%)
Macquarie Group Ltd
4,746,776 (6.238%)
Macquarie Investment Management Aus Ltd.
4,746,776 (6.238%)
Morgan Stanley - Brokerage Accounts
4,136,290 (5.435%)
SSGA Funds Management Inc
4,065,804 (5.343%)
Macquarie Investment Management Advisers
3,607,771 (4.741%)
Funds Holdings
SPDR® S&P Biotech ETF
4,029,863 (5.296%)
Delaware Small Cap Core Fund
3,565,035 (4.685%)
iShares Russell 2000 ETF
1,781,655 (2.341%)
Pictet Biopharmaceutical Mother
1,089,600 (1.432%)
Vanguard Institutional Extnd Mkt Idx Tr
987,089 (1.297%)
Fidelity Small Cap Index Fund
725,345 (0.953%)
iShares Russell 2000 Growth ETF
599,744 (0.788%)
iShares Biotechnology ETF
540,256 (0.710%)
Vanguard Strategic Equity Fund
509,538 (0.670%)
Principal SmallCap Growth Fund I
470,308 (0.618%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
